Narcolepsy Meeting Focuses on Symptoms, But Some Urge Attention to Underlying Cause

The Pink Sheet, October 7, 2013

Excessive daytime sleepiness, interrupted nighttime sleep and “brain fog” are key symptoms that new drugs developed for the treatment of narcolepsy should target, patients told FDA Sept. 24.

During a four-hour meeting held as part of the agency’s patient-focused drug development initiative, dozens of patients and caregivers talked about the daily struggle to cope with the symptoms of narcolepsy despite currently approved treatments.

Read more.